Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | CDC25A | P30304 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | CDC25C | P30307 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19825307 | 0.88 | RECQL (0.50) | RECQLALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16476083 | 0.85 | ABCG2 (0.41) | RECQLALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL13274138 | 0.81 | RECQL (0.48) | RECQLALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL19631279 | 0.81 | RECQL (0.44) | RECQLALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL19825281 | 0.76 | RECQL (0.40) | RECQLALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL18535350 | 0.76 | RECQL (0.51) | RECQLALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL19494991 | 0.75 | RECQL (0.42) | RECQLALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL24799971 | 0.75 | ALDH1A1 (0.41) | RECQLALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL6743766 | 0.74 | RECQL (0.50) | RECQLALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL1847539 | 0.73 | RECQL (0.49) | RECQLALDH1A1CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4218832-A2 | METHODS AND COMPOSITIONS FOR 18F-RADIOLABELING OF THE FIBRONECTIN TYPE (III) DOMAIN | Bristol-Myers Squibb Company (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2017210335-A1 | IMAGING METHODS USING 18F-RADIOLABELED BIOLOGICS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-12-07 | — | — | WO | disclosed |